@article{3219698,
    title = "Effect of Long-Term Hydroxytyrosol Administration on Body Weight, Fat Mass and Urine Metabolomics: A Randomized Double-Blind Prospective Human Study",
    author = "Fytili, C. and Nikou, T. and Tentolouris, N. and Tseti, I.K. and Dimosthenopoulos, C. and Sfikakis, P.P. and Simos, D. and Kokkinos, A. and Skaltsounis, A.L. and Katsilambros, N. and Halabalaki, M.",
    journal = "Nutrient Cycling in Agroecosystems",
    year = "2022",
    volume = "14",
    number = "7",
    publisher = "MDPI",
    issn = "1385-1314",
    doi = "10.3390/nu14071525",
    keywords = "3,4-dihydroxyphenylethanol;  phenethyl alcohol, body weight;  controlled study;  double blind procedure;  female;  human;  metabolomics;  obesity;  prospective study;  randomized controlled trial, Body Weight;  Double-Blind Method;  Female;  Humans;  Metabolomics;  Obesity;  Overweight;  Phenylethyl Alcohol;  Prospective Studies",
    abstract = "Hydroxytyrosol (HT) is a natural antioxidant found in olive products and characterized by well-documented beneficial effects on human health. Several research studies are ongoing that aim to investigate its potency and molecular mechanism of action. The present study aimed to investigate the potential effect of HT on human obesity through a randomized double-blind prospective design. HT in two different doses (15 and 5 mg/day) and a placebo capsule was administered to 29 women with overweight/obesity for six months and their weight and fat mass were monitored at three time points (baseline, 4, 12 and 24 weeks). Statistically significant weight and visceral fat mass loss (%weight loss: p = 0.012, %visceral fat loss: p = 0.006) were observed in the group receiving the maximum HT dosage versus placebo after 4 weeks of the intervention, with attenuation of these findings at 12 and 24 weeks of the study. Urine samples were collected during the intervention and analyzed via liquid chromatography–high-resolution mass spectrometry for untargeted metabolomic purposes and comparisons between study groups were performed. HT administration was safe and well-tolerated. To the best of our knowledge, this is the first human cohort investigating the effects of HT on obesity for a prolonged study period. © 2022 by the authors. Licensee MDPI, Basel, Switzerland."
}